Vaccine trial launched in Oxford in response to deadly outbreak
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Read the full articleYou might also wanna read
Oxford, Serum Institute Launch First Human Trial for New Ebola Vaccine
Oxford and Serum Institute have launched the first human trial of a vaccine targeting the deadly Bundibugyo strain of Ebola virus.
Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to co
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 13 (Reuters) - The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accel
Oxford Ebola Vaccine: What to Know About the New Shot Entering Human Trials
Oxford has launched the first human trial of a vaccine targeting the Bundibugyo strain of Ebola, as the death toll in the Democratic Republi
Oxford Vaccine Group launches world’s first Phase I Bundibugyo ebolavirus vaccine trial
The BDBV strain is responsible for the ongoing ebola outbreak in the Democratic Republic of the Congo (DRC), and Uganda
CEPI-backed Ebola vaccine set to enter phase 1 trials
The first vaccine against the Bundibugyo ebola virus is poised to enter phase 1 clinical trial.
Comments
Sign in to join the conversation.
No comments yet. Be the first.